Longevity Investors Conference (LIC) returns for its third annual edition from Sept. 28–30 in Gstaad, Switzerland.
The conference attracts the world’s top longevity leaders, institutional and private investors, wealthy private investors and family offices and funds in an exclusive setting. For two days, opinion leaders and high-ranking representatives will exchange their knowledge about longevity, trends, attractive investments and business opportunities in the longevity space. The conference will ensure a private atmosphere and the opportunity to establish partnerships with other business leaders and investment opportunities in a unique setting at Le Grand Bellevue, a five-star hotel in Gstaad and one of the most exclusive Swiss mountain resorts.
The LIC has the honor of welcoming leading longevity experts and scientists, such as Harvard Medical School genetics professor George Church, SENS Research Foundation chief of science offices Aubrey de Grey, Buck Institute for Research on Ageing president and CEO Eric Verdin, Institute for Ageing Research at Albert Einstein College of Medicine director Nir Barzilai, Forever Healthy Foundation founder Michael Greve, Human Longevity Inc. associate professor, internal medicine specialist and longevity physician Evelyne Yehudit Bischof, Insilico Medicine founder and CEO Alex Zhavoronkov, First Longevity founder and Longevity.Technology editor-in-chief Phil Newman, and Wei-Wu He, Human Longevity Inc. executive chairman, Casi Pharmaceuticals Inc. CEO and chairman, and Genetron Health founder and chairman.
More speakers will be announced closer to the conference.
LIC was initiated by Tobias Reichmuth and Marc Bernegger, two successful serial entrepreneurs who, among others, launched CfC St. Moritz, one of the most exclusive conferences for digital assets.
Keynote speeches, fireside chats, panel discussions and breakout sessions on topics including biotech, aging technology, diagnostics, AI, health prevention, longevity therapy and investment strategy await the attendees of the 2022 conference.
The conference is in the Bellevue Hotel in Gstaad, recently rated Hotel of the Year by the Swiss media. The hotel will be privatized for LIC’s guests, ensuring an exclusive networking experience. Some of the conference’s partners include PricewaterhouseCoopers, Credit Suisse, Maximón, Korify Capital, Apollo Health Ventures, Clinique La Prairie, Biolytica AG, Avea Solutions and many more.
The unique event format combines rich content and insight-sharing during the day, with numerous opportunities to recharge and network at the lunches, evening receptions, dinners and longevity experiences occurring during the course of the two-day conference.
“There are more and more traditional investors joining the longevity space, which creates massive investment opportunities. The special setup of this year’s conference enables not only knowledge exchange but also effective community-building, which is very unique for the industry and has never happened before to this extent,” said Marc Bernegger, one of the driving forces behind the conference.
Tobias Reichmuth, co-founder of LIC and Bernegger’s partner, said, “The longevity industry will be one of the biggest investment opportunities during the next decade — expected to be worth at least $600 billion by 2025. It is experiencing great momentum, and this is the ideal time to use it in favor of educating and spreading information to investors. In a sea of science-oriented conferences, a professional and global investor-focused longevity conference such as LIC will provide an opportunity for the industry’s top investors and innovators to get acquainted with recent developments and breakthroughs.”
Early bird tickets are available until the end of June on the site.